Fundamentals of Medicinal Chemistry

(Brent) #1
(a)

Plasma
concentration

Time Time

0

Concentration
in the excreted
urine

0

(b)

Figure 8.2 Typical variations in the concentration of a drug with time in samples of (a) plasma


and (b) urine after the administration of a single oral dose of the drug at time zero. In both cases


the precise shape of the graph will depend on the drug being studied


The process of elimination means that it is important to have a method of

monitoring the concentration of a drug in contact with its site of action. Since

the precise site of action is often unknown the concentration of the drug is

usually monitored by following the concentration of the drug in the plasma and

other suitable body fluids (Figure 8.2). These measurements are statistically

correlated with the effects of the drug on humans and, where this data is difficult

to obtain, animals. However, the results of these animal experiments have been

extrapolated to humans with varying degrees of success.

8.1.1 General classification of pharmacokinetic properties


The pharmacokinetic properties (ADME, see section 2.7.1) of a drug are speci-

fied in terms of measurable parameters such as plasma concentration, biological

half-life and rate constants. The methods used to calculate these parameters are

independent of the method of administration, although the values obtained will

depend on the administrative route (see section 2.6). For example, intravascular

routes will not normally give values for absorption parameters. However,

intravascular routes do give higher concentrations of the drug in the general

circulatory system (systemic circulatory system).

8.2 Pharmacokinetics and drug design


A study of the pharmacokinetic properties of a compound indicates which

properties need to be modified in order to produce a more effective analogue.

Consider, for example, a drug that is not suitable for development because it has

too short a duration of action. The logical way forward is to determine the likely

structural cause of this rapid elimination and then test analogues that either do

160 PHARMACOKINETICS

Free download pdf